mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.002 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.002 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |